[Treatment of dyspepsic syndromes with Diskiline].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D004338:Drug Combinations; D004341:Drug Evaluation; D004357:Drug Synergism; D004415:Dyspepsia / Q000188:drug therapy*; D004987:Ethers / Q000627:therapeutic use; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use*; D008875:Middle Aged; D010194:Pancreatin / Q000627:therapeutic use*; D010434:Pepsin A / Q000627:therapeutic use*; D012828:Silicones / Q000627:therapeutic use*
D004338:Drug Combinations; D004987:Ethers; D005765:Gastrointestinal Agents; D006885:Hydroxybutyrates; D012828:Silicones; D010194:Pancreatin; D010434:Pepsin A; D008787:Metoclopramide
Tratamiento de los síndromes dispépticos con Diskilene